- ￥600 - 3200
- 上海莼试
- CS-01Y72699
- 国产
- 2025年07月13日
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
51
- 英文名：
Vancomycin
- CAS号：
1404-90-6
- 供应商：
上海莼试
- 保存条件：
Store at -20°C
- 规格：
250mg
分子式:C66H75Cl2N9O24
分子量:1449.25
溶解度:5mg/ml in PBS (pH 7.2)
储存条件:Store at -20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition:Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
Vancomycin is an antibiotic for the treatment of bacterial infections.Vancomycin is a large glycopeptide compound with a molecular weight of 1450 Da[1]. Vancomycin is a unique glycopeptide structurally unrelated to any currently available antibiotic. It also has a unique mode of action inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin is active against a large number of species of Gram-positive bacteria, such as Staphylococcus aureu, Staph. epidermidis, Str. agalactiae, Str. bovis, Str. mutans, viridans streptococci, enterococci[2].Vancomycin is administered intravenously, with a standard infusion time of at least 1 h, to minimize infusion-related adverse effects. Subjects with normal creatinine clearance, vancomycin has an α-distribution phase of 30 min to 1 h and a β-elimination half-life of 6-12 h. The volume of distribution is 0.4-1 L/kg. The binding of vancomycin to protein ranges from 10% to 50%. Factors that affect the overall activity of vancomycin include its tissue distribution, inoculum size, and protein-binding effects[1]. Vancomycin treatment of infected mice is associated with improved clinical, diarrhea, and histopathology scores and survival during treatment[3].[1]. Rybak MJ, et al. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S35-9. [2]. Watanakunakorn C, et al. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother. 1984 Dec;14 Suppl D:7-18. [3]. Warren CA, et al. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013 Feb;57(2):689-96.
商品属性：
| 货号 | CS-01Y72699 | 规格 | 250mg |
| CAS号 | 1404-90-6 | 分子量 | 1449.25 |
| 含量 | >98.00% | 别名 | N/A |
| 分子式 | C66H75Cl2N9O24 | 化学名 | N/A |
| 产地 | 国产 | 用途 | 仅供科研研究实验 |
抗逆滴加序列
每次向板内滴加抗原时，移液器滴头要与平面45度悬空，不要触碰到孔内的液体，由后向前依次滴加(即浓度由低往高滴加)。
抗感染反应期
抗原抗体在室温20~25℃下，必须反应30min以上，若环境温度低于室温，可将微量反应板置于恒温培养箱中，使二者充分反应。
旅游温度
磷酸盐缓冲液的pH值要在高压灭菌后进行滴定，往往在高压后pH值会有所改变，所以高压后再调一次pH值更为准确。磷酸盐缓冲液一经使用保存期不要超过3周。当pH<5.8时，红细胞会产生自凝现象;当pH>7.8时，图形洗脱加快，易造成肉眼观察产生误差;p H=7.2时，红细胞沉降最充分，图形最清晰。
当滴注 1%红细胞悬液时，应经常摇晃红细胞悬液，使红细胞均匀地分布在磷酸缓冲液中，以防止红细胞下降。
反应时间及温度
加入鸡红血球之后，反应板在室温(20~25℃)静置30~40min，对照孔血球下沉于孔底，即可判定结果。若室温达不到实验要求，需相应调整反应时间。当环境温度低于4℃时，红细胞发生自凝;高于37℃时，会发生反应物分离和红细胞溶血。
公司正在出售的产品：
| BQR-695 (NVP-BQR695) | Tadalafil |
| Rosuvastatin D3 Sodium | Peroxisome Proliferator-activated receptor γ,PPAR-γ ELISA Kit |
| α-D-Glucose-1,6-bisphosphate (potassium salt hydrate) | peroxisome proliferative activated receptor gama coactivator 1 alpha,PPARGC1 ELISA Kit |
| τ-Fluvalinate | Complement fragment 4a,C4a ELISA Kit |
| KMN-80 | Catalase,CAT ELISA kit |
| Fusaric Acid | ALDOA ELISA kit |
| Lysophosphatidylethanolamines (egg) | fructosamin,FRA ELISA kit |
| Trigonelline | 大鼠髓过氧化物酶特异性抗中性粒细胞胞质抗IgG(MPO-ANCA IgG)ELISA Kit |
| Fonadelpar (NPS-005) | lipid peroxide,LPO ELISA kit |
| Ammonium iron(III) citrate | lipid peroxlde,LPO ELISA Kit |
| IDO inhibitor 1 | PNPLA3/ADPN/C22orf20 ELISA kit |
| Aminophylline | setd4 ELISA Kit |
| Gimeracil | VancomycinTie-1 ELISA Kit |
| Purvalanol A | Tie-2 ELISA Kit |
| NMP22 ELISA Kit | HV IgM ELISA kit |
1.本蛋白酶抑制剂混合物为100×的储存液，使用时按照1:100的比例加入到裂解液中(例如，1ml裂解液中加入10μl蛋白酶抑制剂混合物)，混匀后即可使用。根据需要，0.5M的EDTA也按照1:100的比例加入到裂解液中（如用于检测金属蛋白酶活性，则不宜添加EDTA）。含有蛋白酶抑制剂混合物的裂解液宜现用现配，不宜配制后冻存待后续使用。
2. 待所需的抑制剂添加完毕混匀后，就可以开始进行哺乳动物组织的裂解和蛋白提取。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection Methods of Glycopeptide-Resistant Staphylococcus aureus I: Susceptibility Testing
The breakpoint for resistance to vancomycin for Staphylococcus aureus is a minimum inhibitory concentration (MIC) of greater than 8 μg/mL (1 ). Isolation of the first strain of MRSA resistant to vancomycin (VRSA) Mu50
Use of Macrocyclic Antibiotics as the Chiral Selectors in Capillary Electrophoresis
Macrocyclic antibiotics, especially vancomycin, represent a class of versatile chiral selectors for enantioseparations by capillary electrophoresis (CE). In this chapter, we describe the protocol for performing CE enantioseparations
Treatment of Infections Due to Resistant Staphylococcus aureus
up to January of 2013. Despite the emergence of resistant and multidrug-resistant S. aureus , we have seven effective drugs in clinical use for which little resistance has been observed: vancomycin, quinupristin–dalfopristin, linezolid, tigecycline, telavancin
技术资料暂无技术资料 索取技术资料
